Eosinophilic Gastroenteritis

https://doi.org/10.1016/j.gtc.2008.02.003Get rights and content

Eosinophilic gastroenteritis is an infrequently diagnosed condition that is characterized by prominent eosinophilic infiltration of the stomach or small intestine, generally localized to one level of the intestinal wall; the variable organ locus and wall depth produce heterogeneous clinical presentations. A strong association with atopy is present in most cases, supported by circumstantial evidence and the demonstration of Th-2 proinflammatory cytokine profiles in animal studies. A high degree of suspicion is required to establish the diagnosis, which must be based on intense gastrointestinal eosinophilia. Management is directed toward removal of offending allergens and use of anti-inflammatory agents. Novel and emerging treatments on the horizon are biologic therapies and selective anti-eosinophil agents.

Section snippets

Epidemiology

Because of a notable scarcity of published data on the epidemiology, it is difficult to determine the true burden of EG. An English language literature review does not reveal a well-analyzed published case series describing primary EG in the last 3 years, suggesting that it is an uncommon and perhaps difficult-to-diagnose disorder. Nevertheless, several case reports of EG have emerged recently in different parts of the world [1], [2], [3], [4], [5]. The diagnosis affects most ethnicities, and

Pathogenesis

EG may be primary, also known as allergic, or secondary to one of many conditions that provoke eosinophilic inflammation (see later section on differential diagnosis), with parasitic infections being the leading cause. The cause cannot be precisely determined in a small but important minority of patients, who are regarded as having idiopathic EG.

Clinical Presentations

Patients who have EG have heterogeneous clinical presentations, some of which overlap with more familiar diagnoses, such as functional GI disorders and inflammatory bowel disease. Presenting symptoms may be vague and nonspecific (eg, recurrent abdominal pain [23]) or dramatic (eg, gastric ulcer perforation [24]). Symptom onset may be at any age, but most patients are diagnosed as young adults, between the third and fifth decades of life. Often patients experience symptoms for many months and

Differential Diagnosis

A broad range of conditions are associated with gastrointestinal mucosal eosinophilia and the following is a brief review of some of the important differential diagnoses.

Diagnostic Evaluation

Diagnosis of EG requires suspecting the disease, excluding other disorders in the differential diagnoses, confirming the definitive diagnosis, and assessing for potential complications. Currently accepted diagnostic criteria are the presence of gastrointestinal symptoms, an intense eosinophilic infiltrate on histopathologic examination, and exclusion of other causes of intestinal eosinophilia. Tests considered useful in the evaluation of EG and its differentials are presented in Table 1[62].

A

Management

Various treatments may be beneficial in EG [76]. Our current knowledge of the treatment of EG is derived virtually exclusively from small studies and anecdotal experience. Evidence for the true efficacy of any therapy suffers from the lack of well-designed and controlled studies. Nevertheless, corticosteroids and dietary therapy are two treatment interventions for which the data are convincingly favorable. Emerging treatments in development are biologics and selective anti-eosinophil agents.

Natural History

There is a dearth of information about the long-term course of patients who have treated or untreated EG. Most experts regard primary EG as a chronic disorder characterized by relapses and remissions, and hence the recommendations for close follow-up and perhaps repeated endoscopic surveillance in selected cases. The natural history of EG has not been well described, but clinical studies point to a chronic relapsing course for patients who have this diagnosis. The long-term follow-up (2.5 to

Summary

EG is an uncommon, yet important, entity in the spectrum of primary EGIDs, selectively affecting the stomach and small intestine with an eosinophilic inflammatory process. Multiple clinical presentations are recognized because of the variability in the location and depth of eosinophilic infiltration. History of atopy and allergies is present in 25% to 75% of cases. Recent investigations providing an insight into the pathogenesis of EG support a critical role for allergens, eosinophils,

References (90)

  • R.A. Wood et al.

    Accuracy of IgE antibody laboratory results

    Ann Allergy Asthma Immunol

    (2007)
  • H.A. Sampson et al.

    Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents

    J Allergy Clin Immunol

    (1997)
  • J.M. Spergel et al.

    Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis

    J Allergy Clin Immunol

    (2007)
  • S. Pungpapong et al.

    Protein-losing enteropathy from eosinophilic enteritis diagnosed by wireless capsule endoscopy and double-balloon enteroscopy

    Gastrointest Endosc

    (2007)
  • Y.Y. Chen et al.

    Eosinophilic jejunitis presenting with acute abdomen: the usefulness of double-balloon enteroscopy

    Gastrointest Endosc

    (2006)
  • A.F. Kagalwalla et al.

    Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis

    Clin Gastroenterol Hepatol

    (2006)
  • E. Siewert et al.

    Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide

    Dig Liver Dis

    (2006)
  • J.E. Teitelbaum et al.

    Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

    Gastroenterology

    (2002)
  • M. Remedios et al.

    Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate

    Gastrointest Endosc

    (2006)
  • J.K. Garrett et al.

    Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes

    J Allergy Clin Immunol

    (2004)
  • M.L. Stein et al.

    Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis

    J Allergy Clin Immunol

    (2006)
  • S. Foroughi et al.

    Anti-IgE treatment of eosinophil-associated gastrointestinal disorders

    J Allergy Clin Immunol

    (2007)
  • S.J. Ackerman et al.

    Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders

    Immunol Allergy Clin North Am

    (2007)
  • B.S. Bochner

    Verdict in the case of therapies versus eosinophils: the jury is still out

    J Allergy Clin Immunol

    (2004)
  • C. Elsing et al.

    Budesonide for the treatment of obstructive eosinophilic jejunitis

    Z Gastroenterol

    (2007)
  • W.G. Shin et al.

    Eosinophilic enteritis presenting as intussusception in adult

    Korean J Intern Med

    (2007)
  • M.Y. Yun et al.

    Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature

    World J Gastroenterol

    (2007)
  • M. Chehade et al.

    Multiple exudative ulcers and pseudopolyps in allergic eosinophilic gastroenteritis that responded to dietary therapy

    J Pediatr Gastroenterol Nutr

    (2007)
  • M.J. Chen et al.

    Eosinophilic gastroenteritis: clinical experience with 15 patients

    World J Gastroenterol

    (2003)
  • N.J. Talley et al.

    Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues

    Gut

    (1990)
  • M. Chehade et al.

    Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up

    J Pediatr Gastroenterol Nutr

    (2006)
  • S. Khan et al.

    Eosinophilic gastroenteritis masquerading as pyloric stenosis

    Clin Pediatr (Phila)

    (2000)
  • S. Venkataraman et al.

    Eosinophilic gastroenteritis—an Indian experience

    Indian J Gastroenterol

    (1998)
  • C.M. Lee et al.

    Eosinophilic gastroenteritis: 10 years experience

    Am J Gastroenterol

    (1993)
  • G. Torpier et al.

    Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein

    Clin Exp Immunol

    (1988)
  • G.T. Furuta

    Emerging questions regarding eosinophil's role in the esophago-gastrointestinal tract

    Curr Opin Gastroenterol

    (2006)
  • S.P. Hogan et al.

    Eosinophil function in eosinophil-associated gastrointestinal disorders

    Curr Allergy Asthma Rep

    (2006)
  • S. Khan et al.

    Educational clinical case series in pediatric allergy and immunology

    Pediatr Allergy Immunol

    (2007)
  • N. Mendez-Sanchez et al.

    Eosinophilic gastroenteritis: a review

    Dig Dis Sci

    (2007)
  • S.P. Hogan et al.

    A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation

    Nat Immunol

    (2001)
  • J. Kokkonen et al.

    Mucosal pathology of the foregut associated with food allergy and recurrent abdominal pains in children

    Acta Paediatr

    (2001)
  • E.K. Siaw et al.

    Eosinophilic gastroenteritis presenting as acute gastric perforation

    J Pediatr Gastroenterol Nutr

    (2006)
  • E. Redondo-Cerezo et al.

    Eosinophilic gastroenteritis: our recent experience: one-year experience of atypical onset of an uncommon disease

    Scand J Gastroenterol

    (2001)
  • A.R. Naylor

    Eosinophilic gastroenteritis

    Scott Med J

    (1990)
  • N.C. Klein et al.

    Eosinophilic gastroenteritis

    Medicine (Baltimore)

    (1970)
  • Cited by (86)

    • Eosinophilic Gastroenteritis: Still a Diagnostic Challenge

      2023, GE Portuguese Journal of Gastroenterology
    • Benign Diseases of the Stomach

      2022, Surgical Pathology of the Gastrointestinal System: Volume I-Gastrointestinal Tract
    View all citing articles on Scopus
    View full text